252 related articles for article (PubMed ID: 2334465)
21. General pharmacological profiles of the new beta-adrenoceptor antagonist carvedilol.
Hirohashi M; Takasuna K; Tamura K; Yamaguchi K; Maekawa K; Yamada S; Iwasaki S; Yoshida M; Nomura M; Taguchi K
Arzneimittelforschung; 1990 Jul; 40(7):735-46. PubMed ID: 1977393
[TBL] [Abstract][Full Text] [Related]
22. [Effects of ritodrine hydrochloride on motor nervous system and central nervous system].
Ikeda S; Tsukamoto T
Nihon Yakurigaku Zasshi; 1984 Sep; 84(3):311-26. PubMed ID: 6500405
[TBL] [Abstract][Full Text] [Related]
23. General pharmacology of the novel angiotensin converting enzyme inhibitor benazepril hydrochloride. Effects on central nervous and sensory systems and other functions.
Yamamoto S; Takemori E; Hasegawa Y; Nakao K; Inukai T; Nomura M; Morino K; Tsuchiyama M; Hasegawa K; Ikeda H
Arzneimittelforschung; 1991 Jun; 41(6):602-7. PubMed ID: 1930347
[TBL] [Abstract][Full Text] [Related]
24. [Pharmacological properties of procaterol, a newly synthetized, specific beta 2-adrenoceptor stimulant. Part I. Effects on the CNS (author's transl)].
Hashimoto K; Shintani S; Yamashita S; Tei S; Takai M; Tsutsui M; Kawamura K; Ohkawa T; Hiyama T; Yabuuchi Y
Nihon Yakurigaku Zasshi; 1979 Apr; 75(3):271-89. PubMed ID: 43821
[TBL] [Abstract][Full Text] [Related]
25. General pharmacological profile of the new cognition-enhancing agent nefiracetam.
Kitano Y; Makino M; Usui C; Takasuna K; Kasai Y; Hirohashi M; Tamura K; Takayama S; Kojima H; Iizuka H
Arzneimittelforschung; 1994 Feb; 44(2A):199-210. PubMed ID: 8018090
[TBL] [Abstract][Full Text] [Related]
26. General pharmacological properties of cilostazol, a new antithrombotic drug. Part I: Effects on the central nervous system.
Shintani S; Toba Y; Suzuki S; Ninomiya S; Umezato M; Hiyama T
Arzneimittelforschung; 1985; 35(7A):1157-62. PubMed ID: 4074429
[TBL] [Abstract][Full Text] [Related]
27. General pharmacology of oxepinac.
Kojima H; Hashizume T; Chiba T; Tanaka M; Kasai Y; Kasahara A
Arzneimittelforschung; 1978; 28(3):439-45. PubMed ID: 580753
[No Abstract] [Full Text] [Related]
28. Biological properties of aspartame. I. Evaluation of central nervous system effects.
Potts WJ; Bloss JL; Nutting EF
J Environ Pathol Toxicol; 1980; 3(5-6):341-53. PubMed ID: 7441089
[TBL] [Abstract][Full Text] [Related]
29. Pharmacology of secoverine, a new spasmolytic agent with specific antimuscarinic properties. Part 2: General pharmacological properties.
Zwagemakers JM; Claassen V
Arzneimittelforschung; 1980; 30(9):1526-34. PubMed ID: 7193021
[TBL] [Abstract][Full Text] [Related]
30. Central effects of endogenous and exogenous GABA.
Czajka R
Acta Physiol Pol; 1978; 29(3):193-205. PubMed ID: 707139
[TBL] [Abstract][Full Text] [Related]
31. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
[TBL] [Abstract][Full Text] [Related]
32. [Effects of guanfacine on the central nervous system (author's transl)].
Iizuka H; Imai S
Nihon Yakurigaku Zasshi; 1980 Oct; 76(7):667-74. PubMed ID: 7011921
[TBL] [Abstract][Full Text] [Related]
33. [Neurotoxicity in sodium azide poisoning].
Fujimura T; Kobayashi H; Suzuki T; Sato I; Hara S
Chudoku Kenkyu; 2002 Jul; 15(3):281-8. PubMed ID: 12415870
[TBL] [Abstract][Full Text] [Related]
34. Effects of azelastine hydrochloride, a novel anti-allergic drug, on the central nervous system.
Kaneko T; Kitahara A; Ozaki S; Takizawa K; Yamatsu K
Arzneimittelforschung; 1981; 31(8):1206-12. PubMed ID: 6117290
[TBL] [Abstract][Full Text] [Related]
35. General pharmacology of the novel antiepileptic compound zonisamide. 1st communication: effects on central nervous system.
Hori M; Ito T; Oka M; Noda Y; Matsuno Y; Furukawa K; Ochi Y; Karasawa T; Kadokawa T
Arzneimittelforschung; 1987 Oct; 37(10):1124-30. PubMed ID: 3435583
[TBL] [Abstract][Full Text] [Related]
36. [General pharmacologic studies on the analgesic flupirtine].
Jakovlev V; Achterrath-Tuckermann U; von Schlichtegroll A; Stroman F; Thiemer K
Arzneimittelforschung; 1985; 35(1):44-55. PubMed ID: 4039152
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of neural and neuroendocrine activity by alpha-interferon: neuroendocrine, electrophysiological, and biochemical studies in the rat.
Saphier D; Roerig SC; Ito C; Vlasak WR; Farrar GE; Broyles JE; Welch JE
Brain Behav Immun; 1994 Mar; 8(1):37-56. PubMed ID: 8003770
[TBL] [Abstract][Full Text] [Related]
38. Pharmacological studies of o-chloro-alpha-[(tert.-butylamino)methyl]benzylalcohol hydrochloride (C-78), a new bronchodilator. III. Actions on the nervous systems and miscellaneous organs.
Uesaka I; Kubo S; Matsubara I; Kasé Y
Arzneimittelforschung; 1977 Jul; 27(7):1439-45. PubMed ID: 578469
[TBL] [Abstract][Full Text] [Related]
39. Central action of glucagon.
Morawska D; Sieklucka-Dziuba M; Kleinrok Z
Pol J Pharmacol; 1998; 50(2):125-33. PubMed ID: 9798264
[TBL] [Abstract][Full Text] [Related]
40. General pharmacology of the putative cognition enhancer linopirdine.
Flagmeyer I; Gebert I; van der Staay FJ
Arzneimittelforschung; 1995 Apr; 45(4):456-9. PubMed ID: 7779141
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
